Praxis Precision Medicines (PRAX) Enterprise Value (2019 - 2026)

Praxis Precision Medicines' Enterprise Value history runs 8 years deep, the most recent figure standing at -$786.9 million for Q1 2026.

• In Q1 2026, Enterprise Value fell 139.9% year-over-year to -$786.9 million; the TTM figure through Mar 2026 stood at -$786.9 million (down 139.9% YoY), while the FY2025 annual figure was -$599.3 million, down 52.67% from the prior year.
• Enterprise Value was -$786.9 million for Q1 2026 at Praxis Precision Medicines, down from -$599.3 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$56.0 million in Q2 2022 to a low of -$786.9 million in Q1 2026.
• Historically, Enterprise Value has averaged -$249.2 million across 5 years, with a median of -$207.4 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Enterprise Value jumped 68.14% in 2022, then plunged 382.86% in 2024.
• A 5-year view of Enterprise Value shows it stood at -$61.6 million in 2022, then tumbled by 31.95% to -$81.3 million in 2023, then slumped by 382.86% to -$392.6 million in 2024, then slumped by 52.67% to -$599.3 million in 2025, then sank by 31.29% to -$786.9 million in 2026.
• The last three Enterprise Value figures came in at -$786.9 million (Q1 2026), -$599.3 million (Q4 2025), and -$267.2 million (Q3 2025), per Business Quant data.